ArticleOphthalmology science2026
Demographic and Ocular Factors Associated with Suprachoroidal Space Thickness in Healthy Eyes.
Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Stepwise 900 µm to 1100 µm Microneedle Selection for Suprachoroidal Triamcinolone Acetonide.Journal of vitreoretinal diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Purpose: The suprachoroidal space (SCS) is an emerging route for drug delivery and gene therapy. Here, we analyze demographic and ocular factors associated with SCS visibility and thickness on enhanced-depth imaging OCT (EDI-OCT) in a large cohort of healthy human eyes to better understand variations in macular SCS measurements. Design: Retrospective, cross-sectional study. Subjects: Six hundred twenty-four healthy eyes of 624 patients with no retinal pathologies. Methods: We analyzed EDI-OCT images of eyes with no retinal pathologies from patients seen at the University of California, Davis between September 1, 2014 and December 31, 2023. We performed image segmentation and measured SCS visibility and thickness along the 6-mm segment around the fovea, as well as retinal and choroidal thicknesses. Univariate and multivariate regression analyses were used to determine the association of SCS visibility and thickness with demographic and ocular factors including age, sex, race, refractive error, and retinal and choroidal thicknesses. Main Outcome Measures: Association of SCS visibility and thickness with demographic and ocular factors. Results: In healthy subjects (mean age 64.7, range 14-98 years), the choroidal-scleral junction was visible on EDI-OCT in 462 of 624 eyes (74%), among which a hyporeflective SCS layer could be discerned in 214 eyes (46%). The SCS layer was more likely to be present in older ( Conclusions: Suprachoroidal space anatomy varies with age and race. Understanding factors associated with SCS measurements could help inform future research focused on SCS-targeted therapies or patient selection in future clinical trials. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.